What does Lantheus Medical Imaging do?

About Us. At Lantheus, we develop, manufacture and commercialize essential diagnostic imaging agents and products that help healthcare professionals identify disease and improve patient treatment and care.

Who owns Lantheus?

Avista Capital Partners
In 2008, BMS Medical Imaging was acquired by Avista Capital Partners, a private equity firm based in New York City, and was formally re-launched as Lantheus Medical Imaging. In June 2015, parent company Lantheus Holdings [LNTH] became a NASDAQ listed company.

Who bought Progenics?

Lantheus
Lantheus buys Progenics after Velan Capital’s approval.

Is LNTH a buy?

Lantheus has received a consensus rating of Buy. The company’s average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.

What happened Pgnx stock?

(“Progenics”) (Nasdaq: PGNX), an oncology company developing innovative medicines and artificial intelligence to find, fight and follow cancer. The merger agreement was first announced on October 2, 2019. The Company will continue to trade on Nasdaq under the ticker symbol LNTH. Progenics is being delisted.

What is Pgnx?

Progenics Pharmaceuticals (PGNX)

What does azedra treat?

A drug that contains a form of radioactive iodine and is used to treat adults and children aged 12 years and older with certain types of malignant pheochromocytoma or paraganglioma that have spread or cannot be removed by surgery. It is also being studied in the treatment of other types of cancer.

Who bought Pgnx?

pgnx dropped 5.5% in premarket trading Wednesday, even though the cancer treatment developer agreed to be acquired by Lantheus Holdings Inc. LNTH, -3.94% in an all-stock deal, given the sharp selloff in Lantheus shares.

What happened to Pgnx?

Is azedra a chemotherapy?

Azedra is radiotherapy drug. It is comprised of two different portions: iobenguane which accumulates in the adrenal glands and a radioactive isotope as a source of radiation (I131).

How much does azedra cost?

The cost for Azedra intravenous solution – is around $9,468 for a supply of 1 solution, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans. Azedra is available as a brand name drug only, a generic version is not yet available.

How is azedra administered?

Azedra is administered into a vein (intravenous). The regimen is administered in two steps; the dosimetric step, in which the therapeutic dose is determined, and the therapeutic step, where the patient actually receives the dose for treatment.